BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8395321)

  • 1. [Clinical study of Chinese ofloxacin].
    Hou SR
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):238-41, 255-6. PubMed ID: 8395321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever.
    Tanphaichitra D; Srimuang S
    Drugs Exp Clin Res; 1988; 14(8):529-31. PubMed ID: 3266853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections.
    Peng MY
    J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever.
    Tanphaichitra D; Srimuang S
    J Chemother; 1989 Jul; 1(4 Suppl):853-4. PubMed ID: 16312669
    [No Abstract]   [Full Text] [Related]  

  • 5. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
    Naber KG; Sigl G
    Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
    Hasçelik G
    Mikrobiyol Bul; 1987 Jul; 21(3):165-71. PubMed ID: 3332699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical effect and laboratory observation of ofloxacin in the treatment of typhoid fever, bacillary dysentery and gonorrhea].
    Zou QY; Wang QN; Jiang YF
    Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):572-4, 596. PubMed ID: 1806341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of ofloxacin in the treatment of chronic complicated urinary tract infection].
    Uchibayashi T; Nishino A; Motoi I; Hisazumi H; Sawaki M; Orito M; Koizumi H; Shyoda R; Nagano K; Kobashi K
    Hinyokika Kiyo; 1990 Jun; 36(6):725-30. PubMed ID: 2239569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ofloxacin in urinary tract infections.
    Kromann-Andersen B; Krøyer Nielsen K
    Scand J Infect Dis Suppl; 1990; 68():35-40. PubMed ID: 2218420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of ofloxacin in 45 cases of infection of the lower urinary tract in women].
    Bottino G; Marinello M; Menna C; Vergano RM
    Minerva Ginecol; 1989 Nov; 41(11):541-2. PubMed ID: 2622580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial of ofloxacin (Tarivid R)].
    Belovezhdov N; Angelova I; Talakova Ch
    Vutr Boles; 1988; 27(3):67-71. PubMed ID: 3061178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tavanik effectiveness and safety in the treatment of urinary tract infection complications].
    Loran OB; Pushkar' DIu; Rasner PI
    Klin Med (Mosk); 2001; 79(12):35-8. PubMed ID: 11840809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of ofloxacin against complicated urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of ofloxacin versus cefazolin in lower respiratory tract infections.
    Bariffi F; Giacomelli P; Sanduzzi A; Perna F; De Masi AL
    Int J Clin Pharmacol Res; 1987; 7(3):199-201. PubMed ID: 3474212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical reevaluation of ofloxacin (OFLX) in urinary tract infections].
    Akiyama T; Matsuura T; Kurita T
    Hinyokika Kiyo; 1988 Jan; 34(1):201-4. PubMed ID: 3163875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of ofloxacin in complicated urinary tract infection].
    Akazawa N; Tsugawa M; Hayata S; Sasaki H; Asahi T; Okita K
    Hinyokika Kiyo; 1988 Jul; 34(7):1279-82. PubMed ID: 3177148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.